Ornidazole

DB13026InvestigationalSmall molecule

Ornidazole is a nitroimidazole agent indicated in the treatment of infections such as trichomoniasis, amebiasis, and giardiasis. Ornidazole has been used in trials studying the prevention of Elective Colorectal Surgery.

Formula / weight: C₇H₁₀ClN₃O₃ · 219.63 g/mol (avg)

Resolves to

Compound

UNII62XCK0G93TCAS16773-42-5ChEMBLCHEMBL1449676ChEBI75176PubChem28061

Clinical / RWD

RxNorm7701ATCG01AF06ATCJ01RA05ATCJ01RA09

Structure

InChIKeyIPWKIXLWTCNBKN-UHFFFAOYSA-NSMILESCC1=NC=C(N1CC(O)CCl)N(=O)=O

Targets

P00915CA1P00918CA2

What you can answer from here — as of July 10, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

23Drug interactionsStructured to mechanism, not free text

6Clinical trialsPhase, status and sponsor resolved per trial

9Structured indicationsCondition, population, route and combination as fields, not prose

1ContraindicationEach with its own population and attribute set

44Marketed productsAcross 4 countries and 25 labellers

7ATC codesIncluding every combination product, plus 16 drug categories

7+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ornidazole, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account